Fibrocell Science, Inc. announced the earnings results for the year ended December 31, 2017. For the year, the company reported net loss increased to diluted net loss of $1.33 per share as compared to $1.18 per share for the same period last year. Fibrocell used approximately $17.0 million in cash for operations during the twelve months ended December 31, 2017, as compared to approximately $29.4 million used for the same twelve-month period in 2016.